Data / Form D filings / NewLeaf Symbiotics, Inc.
NewLeaf Symbiotics, Inc.: Form D filings
NewLeaf Symbiotics, Inc., an agriculture company in St. Louis, MO, filed 11 Form D notices with the SEC between 2012 and 2023. The latest, on December 21, 2023, reports $47 million sold of a $47 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1005 N. WARSON RD., St. Louis, MO, 63132
- Phone
- (314) 993-4411
- Industry
- Agriculture
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1553909
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | New notice | $47,006,248 | $47,006,248 | 9 | Dec 12, 2023 | sec.gov | |
| Dec 23, 2022 | New notice | $12,000,000 | $6,745,000 | $5,255,000 | 4 | Dec 13, 2022 | sec.gov |
| Dec 13, 2021 | New notice | $15,000,000 | $10,000,000 | $5,000,000 | 5 | Dec 7, 2021 | sec.gov |
| Feb 25, 2020 | New notice | $35,000,000 | $20,518,541 | $14,481,459 | 6 | Feb 14, 2020 | sec.gov |
| Jan 8, 2020 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 1 | Dec 23, 2019 | sec.gov |
| Jul 10, 2017 | New notice | $30,000,000 | $23,827,046 | $6,172,954 | 15 | Jun 28, 2017 | sec.gov |
| Mar 27, 2017 | New notice | $3,551,078 | $3,551,078 | 9 | Mar 14, 2017 | sec.gov | |
| Sep 15, 2014 | New notice | $17,000,000 | $17,000,000 | 16 | Sep 12, 2014 | sec.gov | |
| Jan 18, 2013 | New notice | $5,550,000 | $4,800,000 | $750,000 | 4 | Jan 3, 2013 | sec.gov |
| Jan 8, 2013 | Amendment | $1,175,000 | $1,175,000 | 8 | Nov 3, 2011 | sec.gov | |
| Aug 31, 2012 | New notice | Indefinite | $850,000 | 6 | Nov 3, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Pasquesi | Director | |
| Michael Frodyma | Executive Officer | |
| David Flack | Executive Officer | |
| Brent Smith | Executive Officer, Director | |
| Molly Edwards | Executive Officer | |
| Paul Schickler | Director | |
| Stephen Kahn | Executive Officer, Director | |
| Sanjeev Krishnan | Director | |
| Shawn Semones | Executive Officer | |
| David Purschke | Executive Officer | |
| Aaron Kelley | Executive Officer | |
| Natalie Breakfield | Executive Officer | |
| David Prend | Director |
Every Form D from the week of Dec 18, 2023 · All recent filings in Missouri · All recent Agriculture filings
Read from SEC EDGAR. Amount sold is what NewLeaf Symbiotics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.